Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer.

Funder: Michael Smith Foundation for Health Research

Funding period
CAD 450 K
USD 338 K
Funding amount
Abstract



OBJECTIVE. Bladder cancer is the 5th most common cancer, yet it remains understudied and we are only now making strides in understanding the molecular make-up of this cancer. Recently we and others have discovered that loss of the cell surface receptor Notch-1 drives growth of some bladder cancers, while increased Notch-2 activity drives other bladder cancers. Here we aim to determine how Notch-1 and Notch-2 can lead to such differing effects on cancer growth even though they share many features in common. In addition we aim to design a new drug to inhibit Notch-2 specifically.

SPECIFIC AIMS. To address these objectives, we propose three specific aims:

In our Aim #1 we will create a mouse model that over-expresses Notch-2 specifically in the bladder and we expect this will cause bladder tumours to form. 

In our Aim #2 we will use advanced techniques to study the differences between Notch-1 and Notch- 2 signaling that make them have such different effects. Here we will especially investigate how each Notch protein controls the reading of genes in the cell nucleus.

In the Aim #3 we will develop a new small molecule inhibitor of Notch-2 using computer-aided drug design.


Similar projects All >
Sorted by: Start Date
Project list item
Investigating underlying molecular mechanisms of epigenetic therapies in muscle-invasive bladder cancer

Bladder Cancer Advocacy Network to Swathi Ramakrishnan

USD 1,700
2019 - 2019
Project list item
Recombinant CCL2 as a novel treatment strategy for bladder cancer

Bladder Cancer Advocacy Network to Neelam Mukherjee, Robert Scott Svatek

USD 50,000
2019 - 2020
Project list item
Biomarker-Based Tools for Treatment Response Decision Support of Bladder Cancer

National Cancer Institute to LUBOMIR M HADJIYSKI, AJJAI SHIVARAM ALVA

USD 653,319
2019 - 2024
Project list item
Refined phenotyping and personalized targeting of muscle-invasive bladder cancer

Swiss National Science Foundation to Roland Seiler, Vera Genitsch, Franziska Singer, Kiu Yan Charlotte Ng, Marianna Kruithof-de Julio

USD 597,404
2019 - 2023

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Cancer

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • HRCS RAC

    2.1 Biological and endogenous factors

  • HRCS RAC

    5.1 Pharmaceuticals

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Basic Science